1.
Iniguez AB, Alexe G, Wang EJ, et al. Resistance to Epigenetic-Targeted Therapy Engenders Tumor Cell Vulnerabilities Associated with Enhancer Remodeling. Cancer Cell. 2018;34(6):922-938.e7. doi:10.1016/j.ccell.2018.11.005.
1.
Donaghey J, Thakurela S, Charlton J, et al. Genetic determinants and epigenetic effects of pioneer-factor occupancy. Nat Genet. 2018;50(2):250-258. doi:10.1038/s41588-017-0034-3.
1.
Huang H, Fang M, Jostins L, et al. Fine-mapping inflammatory bowel disease loci to single-variant resolution. Nature. 2017;547(7662):173-178. doi:10.1038/nature22969.
1.
Ichida JK, Staats KA, Davis-Dusenbery BN, et al. Comparative genomic analysis of embryonic, lineage-converted and stem cell-derived motor neurons. Development. 2018;145(22). doi:10.1242/dev.168617.
1.
Lee JY, De Jager PL. What is the epigenome and is it involved in multiple sclerosis?. Mult Scler. 2018;24(3):268-269. doi:10.1177/1352458517750769.
1.
Shooshtari P, Huang H, Cotsapas C. Integrative Genetic and Epigenetic Analysis Uncovers Regulatory Mechanisms of Autoimmune Disease. Am J Hum Genet. 2017;101(1):75-86. doi:10.1016/j.ajhg.2017.06.001.
1.
Wolf EJ, Maniates H, Nugent N, et al. Traumatic stress and accelerated DNA methylation age: A meta-analysis. Psychoneuroendocrinology. 2018;92:123-134. doi:10.1016/j.psyneuen.2017.12.007.
1.
Malik R, Chauhan G, Traylor M, et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50(4):524-537. doi:10.1038/s41588-018-0058-3.
1.
Armenia J, Wankowicz SAM, Liu D, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50(5):645-651. doi:10.1038/s41588-018-0078-z.
1.
Luo H, Xi Y, Li W, et al. Cell identity bookmarking through heterogeneous chromatin landscape maintenance during the cell cycle. Hum Mol Genet. 2017;26(21):4231-4243. doi:10.1093/hmg/ddx312.